FBN1 and metabolic dysfunction-associated steatotic liver disease: Here, HFD or PA treatment lowered p‐AMPK expression while increased p‐p38 expression in mice liver tissues or AML‐12 cells, which were reversed when Asprosin was downregulated, suggesting that inhibition of Asprosin might activate the AMPK‐p38 signaling in NAFLD.